David Amendola, HCC

Director at ResEcon Life Sciences & Healthcare

Speaker

Seasoned life sciences compliance and investigations professional, with over 20 years’ experience working with industry clients, including branded, generic and over-the-counter and medical device companies. Extensive experience leading the development and implementation of proactive compliance monitoring programs across a number of industry risk areas, including bribery and corruption, relationships with health care practitioners and other third parties, as well as assessing the effectiveness of industry compliance programs; led complex global investigations, including alleged violations of the Foreign Corrupt Practices Act (FCPA) and other potential frauds.